Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

BioStratum's Pyridorin effective for diabetic nephropathy

Oct. 30, 1998

Oral insulin formulation developed at Generex headed for U.S. clinical trials

Oct. 30, 1998

Novel vitamin D compounds claimed for use in bone disorders and psoriasis

Oct. 30, 1998

Thiocarbamic acid derivatives as inhibitors of squalene epoxidase

Oct. 29, 1998

Novel class of vitamin D derivatives for metabolic bone diseases, psoriasis

Oct. 29, 1998

Antiprogestin with potential as an oral postcoital contraceptive in women

Oct. 29, 1998

AERx Diabetes Management System enters phase II trials

Oct. 29, 1998

Amylin announces results from pramlintide phase III studies

Oct. 29, 1998

Pivotal clinical trial results with i.v. Hectorol support NDA submission

Oct. 28, 1998

Symbollon begins evaluating fibrocystic breast disease therapeutic in the clinic

Oct. 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 16, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...